Showing 1 - 9 results of 9 for search 'C. Lebbé', query time: 0.02s
Refine Results
-
1
Efficacy of neoadjuvant pembrolizumab in a primary cutaneous stage II non-operated melanoma by M. Amiot, M. Battistella, Maud Bezier, C. Lebbé, B. Baroudjian
Published 2024-12-01
Article -
2
Discoidin domain receptor 1, a melanoma immunomodulator by C. Lutz, A. Lourenço, C. Reger de Moura, B. Louveau, A. Marie-Cardine, C. Lebbé, S. Mourah
Published 2024-01-01
Article -
3
Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1 by C. Reger de Moura, B. Louveau, F. Jouenne, P. Vilquin, M. Battistella, Y. Bellahsen, A. Sadoux, S. Menashi, M. Mancini, N. Dumaz, C. Lebbé, S. Mourah
Published 2024-01-01
Article -
4
Whole transcriptome sequencing: Optimizing molecular classification and management of rare skin cancers by B. Louveau, F. Jouenne, A. Sadoux, M. Mancini, C. Reger de Moura, B. Baroudjian, L. Da Meda, J. Brayet, P. Vilquin, C. Lebbé, M. Battistella, S. Mourah
Published 2024-01-01
Article -
5
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France by S. Dalle, P. Saiag, C. Lebbé, J.-J. Grob, B. Dréno, S. Dalac, B. Asselain, F. Skowron, S. Darras, N. Jovenin, G. Quereux, A. Khammari, C. Rieuf, F. Brellier, S. Houssou, L. Mortier
Published 2024-01-01
Article -
6
HPV vaccination practices among organ transplant recipients in France by J. de Quatrebarbes, J. Chanal, E. Ducroux, M.-T. Leccia, J. Kanitakis, S. Guegan, A. Dadban, B. Sassolas, J. Deylon, N. Malissen, F. Boukari, A. Du Thanh, L. Boussemart, C. Lebbé, S. Barete
Published 2024-01-01
Article -
7
Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets by B. Louveau, I. Nakouri, F. Jouenne, B. Baroudjian, A. Sadoux, L. Da Meda, A. Osio, F. Reinhart, J. Robert, M. Mancini, F. Herms, B. Cribier, L. Mortier, T. Jouary, N. Basset-Seguin, C. Lebbé, S. Mourah, M. Battistella
Published 2024-01-01
Article -
8
Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting by L. Mortier, R. Gutzmer, V. Atkinson, S. Dalle, P. Saiag, B. Neyns, A. Rorive, P. Parente, M. Weichenthal, J.-J. Grob, C. Lebbé, P. Mohr, T. Eigentler, L. McDonald, L. Willemot, F. Brellier, O. Bakharevski, S. Houssou, M. Jadhao, D. Schadendorf
Published 2024-01-01
Article -
9
A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastati... by G.V. Long, R. Gutzmer, A. Haydon, E. Muñoz Couselo, C. Lebbé, M. Carlino, W. Chow, F. Couture, P. Lau, F. Spagnolo, A.J. Alves Wainstein, D. Palmieri, C. Rojas García, G. de Velasco Oria de Rueda, I. Mehmi, D. Patel, A. Shaikh, N.R. Chowdhury, S. Bathena, S. Suryawanshi, P. Rutkowski
Published 2024-01-01
Article